Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Stevanato Group SpA STVN

Technology Scientific & Technical Instruments
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug... see more

Recent & Breaking News (NYSE:STVN)

Stevanato Group Unveils New Plant in Cisterna di Latina for the Production of Pre-Sterilized EZ-fill® Syringes and Cartridges

Business Wire May 30, 2024

Stevanato Group S.p.A. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - STVN

Accesswire May 29, 2024

Lost Money on Stevanato Group S.p.A. (STVN)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

Accesswire May 28, 2024

Stevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco Moro

Business Wire May 28, 2024

Stevanato Group Announces Results of Annual General Meeting

Business Wire May 24, 2024

Stevanato Group to Present at Upcoming Investor Conferences

Business Wire May 23, 2024

Stevanato Group S.p.A. (STVN) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

Accesswire May 21, 2024

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Stevanato Group S.p.A. (STVN)

Accesswire May 20, 2024

Stevanato Being Investigated on Behalf of Stevanato Group S.p.A. Investors. Contact Levi & Korsinsky For Details.

Accesswire May 17, 2024

Stevanato Group Reports Financial Results for the First Quarter of 2024

Business Wire May 9, 2024

Stevanato Group to Present at the Bank of America Securities Healthcare Conference

Business Wire May 1, 2024

Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024

Business Wire April 25, 2024

Stevanato Group appoints Ugo Gay as Chief Operations Officer

Business Wire April 4, 2024

Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters' Option to Purchase Additional Ordinary Shares

Business Wire March 26, 2024

Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares

Business Wire March 21, 2024

Stevanato Group Announces Public Offering of Ordinary Shares

Business Wire March 20, 2024

Stevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum

Business Wire March 11, 2024

Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023

Business Wire March 7, 2024

Stevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024

Business Wire February 22, 2024

Stevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and Commercialization

Business Wire January 24, 2024